Go Pro
→ A “bloodbath” Is Coming (From TradeSmith) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
$4.21
-1.6%		$5.69
$2.44
▼
$32.55
$4.09M-12.40 million shs32,222 shs
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
$0.52
+3.2%		$0.78
$0.43
▼
$2.89
$1.43M0.89274,906 shs119,683 shs
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$0.92
+8.9%		$1.01
$0.80
▼
$16.68
$4.11M0.913.10 million shs875,981 shs
Zynex Inc. stock logo
ZYXI
Zynex
$0.13
$0.12
$0.12
▼
$2.82
$3.80M0.992.32 million shsN/A
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
0.00%-3.66%-20.11%-45.82%-82.72%
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
0.00%-6.32%-14.71%-64.66%-75.55%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00%+2.53%-2.13%-79.37%-85.16%
Zynex Inc. stock logo
ZYXI
Zynex
0.00%0.00%0.00%0.00%-91.67%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
$4.21
-1.6%		$5.69
$2.44
▼
$32.55
$4.09M-12.40 million shs32,222 shs
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
$0.52
+3.2%		$0.78
$0.43
▼
$2.89
$1.43M0.89274,906 shs119,683 shs
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$0.92
+8.9%		$1.01
$0.80
▼
$16.68
$4.11M0.913.10 million shs875,981 shs
Zynex Inc. stock logo
ZYXI
Zynex
$0.13
$0.12
$0.12
▼
$2.82
$3.80M0.992.32 million shsN/A
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
0.00%-3.66%-20.11%-45.82%-82.72%
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
0.00%-6.32%-14.71%-64.66%-75.55%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00%+2.53%-2.13%-79.37%-85.16%
Zynex Inc. stock logo
ZYXI
Zynex
0.00%0.00%0.00%0.00%-91.67%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
2.00
Hold$42.00897.62% Upside
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
1.00
SellN/AN/A
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
1.00
SellN/AN/A
Zynex Inc. stock logo
ZYXI
Zynex
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest BBLG, AMIX, ZYXI, and BJDX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/28/2026
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E) ➝ Sell (E+)
7/24/2026
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/10/2026
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (E+) ➝ Sell (E)
6/24/2026
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/23/2026
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E) ➝ Sell (E+)
(Data available from 9/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
N/AN/AN/AN/A$10.85 per shareN/A
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/AN/AN/AN/A$3.00 per shareN/A
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/A$8.43 per shareN/A
Zynex Inc. stock logo
ZYXI
Zynex
$108.20M0.04$0.25 per share0.51$1.12 per share0.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
-$16.72M-$41.57N/AN/AN/AN/A-267.73%-216.75%11/11/2026 (Estimated)
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
-$3.11M-$1.37N/AN/AN/AN/A-57.87%-53.65%11/13/2026 (Estimated)
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$6.85M-$7.11N/AN/AN/AN/A-125.00%-99.79%11/13/2026 (Estimated)
Zynex Inc. stock logo
ZYXI
Zynex
$2.99M-$2.43N/A0.27N/A-68.35%-804.30%-36.67%N/A

Latest BBLG, AMIX, ZYXI, and BJDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
-$0.39-$0.43-$0.04-$0.43N/AN/A
8/12/2026Q1 2027
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
-$6.40-$5.02+$1.38-$5.02N/AN/A
8/12/2026Q2 2026
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$3,520.00-$1.12+$3,518.88-$1.12N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
N/AN/AN/AN/AN/A
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/AN/AN/AN/AN/A
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/AN/A
Zynex Inc. stock logo
ZYXI
Zynex
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
N/A
4.85
4.85
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/A
8.67
8.67
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/A
4.64
4.64
Zynex Inc. stock logo
ZYXI
Zynex
0.56
0.47
0.32

Institutional Ownership

CompanyInstitutional Ownership
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
10.78%
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
34.30%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
18.47%
Zynex Inc. stock logo
ZYXI
Zynex
29.68%

Insider Ownership

CompanyInsider Ownership
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
6.20%
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
5.00%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
6.10%
Zynex Inc. stock logo
ZYXI
Zynex
49.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
11970,000911,000N/A
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
22.76 million2.62 millionNot Optionable
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
64.47 million4.20 millionNot Optionable
Zynex Inc. stock logo
ZYXI
Zynex
77030.39 million15.41 millionNo Data

Recent News About These Companies

Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm
July 21, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-zynex-inc-to-contact-law-firm-302831417.html
Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm
July 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/13/3326458/0/en/kuehn-law-encourages-investors-of-zynex-inc-to-contact-law-firm.html
ZYXIQ CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
April 21, 2026  |  newsfilecorp.comN
ZYXIQ INVESTOR ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zynex, Inc.
April 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/16/3275368/0/en/ZYXIQ-INVESTOR-ALERT-Bernstein-Liebhard-LLP-Announces-A-Securities-Fraud-Class-Action-Lawsuit-Has-Been-Filed-Against-Zynex-Inc.html
ZYNEX LEAD PLAINTIFF DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Reminds Zynex, Inc Investors to Contact the Firm Before the April 21st Lead Plaintiff Deadline
April 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/13/3272950/0/en/ZYNEX-LEAD-PLAINTIFF-DEADLINE-APPROACHING-Bragar-Eagel-Squire-P-C-Reminds-Zynex-Inc-Investors-to-Contact-the-Firm-Before-the-April-21st-Lead-Plaintiff-Deadline.html
Levi & Korsinsky Notifies Zynex, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – ZYXIQ
April 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/13/3272847/3080/en/Levi-Korsinsky-Notifies-Zynex-Inc-Investors-of-a-Class-Action-Lawsuit-and-Upcoming-Deadline-ZYXIQ.html
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Zynex, Inc. (ZYXIQ)
April 10, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/11/3272087/10782/en/Gainey-McKenna-Egleston-Announces-A-Class-Action-Lawsuit-Has-Been-Filed-Against-Zynex-Inc-ZYXIQ.html
ZYXIQ Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Zynex, Inc. Securities Class Action Lawsuit — The Gross Law Firm
April 10, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/10/3271885/0/en/ZYXIQ-Shareholder-Alert-April-21-2026-Lead-Plaintiff-Deadline-in-Zynex-Inc-Securities-Class-Action-Lawsuit-The-Gross-Law-Firm.html
ZYXIQ EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
April 9, 2026  |  newsfilecorp.comN
ZYXIQ INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Zynex Investors of Securities Class Action Deadline on April 21, 2026
April 3, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/zyxiq-investor-deadline-approaching-faruqi--faruqi-llp-reminds-zynex-investors-of-securities-class-action-deadline-on-april-21-2026-302733401.html
ZYXIQ UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
April 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/01/3266731/683/en/ZYXIQ-UPCOMING-DEADLINE-Faruqi-Faruqi-LLP-Reminds-Zynex-ZYXIQ-Investors-of-Securities-Class-Action-Deadline-on-April-21-2026.html
Zynex, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 21, 2026 to Discuss Your Rights - ZYXIQ
April 1, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/zynex-inc-sued-for-securities-law-violations---contact-levi--korsinsky-before-april-21-2026-to-discuss-your-rights--zyxiq-302731025.html
ZYXI SHAREHOLDER ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements
March 30, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/zyxi-shareholder-alert-hagens-berman-alerts-zynex-zyxi--zyxiq-investors-to-securities-class-action-following-bankruptcy-and-federal-fraud-settlements-302728935.html
ZYXIQ Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zynex, Inc. Securities Lawsuit — The Gross Law Firm
March 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/27/3263906/0/en/ZYXIQ-Shareholder-Alert-Investors-With-Losses-May-Seek-to-Lead-the-Class-Action-in-Zynex-Inc-Securities-Lawsuit-The-Gross-Law-Firm.html
ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements
March 24, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/zyxi-shareholder-update-hagens-berman-alerts-zynex-zyxi--zyxiq-investors-to-securities-class-action-following-bankruptcy-and-federal-fraud-settlements-302723686.html
ZYXIQ CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
March 23, 2026  |  newsfilecorp.comN
ZYXI ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements
March 20, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/zyxi-alert-hagens-berman-alerts-zynex-zyxi--zyxiq-investors-to-securities-class-action-following-bankruptcy-and-federal-fraud-settlements-302720119.html
ZYXI SHAREHOLDER NOTICE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements
March 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/20/3259540/32716/en/ZYXI-SHAREHOLDER-NOTICE-Hagens-Berman-Alerts-Zynex-ZYXI-ZYXIQ-Investors-to-Securities-Class-Action-Following-Bankruptcy-and-Federal-Fraud-Settlements.html
Shareholders that lost money on Zynex, Inc. (ZYXIQ) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
March 18, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/shareholders-that-lost-money-on-zynex-inc-zyxiq-urged-to-join-class-action--contact-levi--korsinsky-to-learn-more-302716978.html
ZYXI INVESTOR ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements
March 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/17/3257798/32716/en/ZYXI-INVESTOR-ALERT-Hagens-Berman-Alerts-Zynex-ZYXI-ZYXIQ-Investors-to-Securities-Class-Action-Following-Bankruptcy-and-Federal-Fraud-Settlements.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Autonomix Medical stock logo

Autonomix Medical NASDAQ:AMIX

$4.21 -0.07 (-1.64%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$4.20 -0.01 (-0.24%)
As of 09/18/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Bone Biologics stock logo

Bone Biologics NASDAQ:BBLG

$0.52 +0.02 (+3.22%)
Closing price 09/18/2026 03:57 PM Eastern
Extended Trading
$0.51 0.00 (-0.39%)
As of 09/18/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Bluejay Diagnostics stock logo

Bluejay Diagnostics NASDAQ:BJDX

$0.92 +0.08 (+8.88%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$0.95 +0.03 (+2.83%)
As of 09/18/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Zynex stock logo

Zynex NASDAQ:ZYXI

$0.12 0.00 (0.00%)
As of 09/18/2026

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas